715
Participants
Start Date
September 30, 2014
Primary Completion Date
April 13, 2017
Study Completion Date
April 13, 2017
HDM-SPIRE
1 dose every 4 weeks
Placebo
1 dose every 4 weeks
Birmingham
Huntington Beach
Long Beach
Mission Viejo
Napa
Orange
Redwood City
Rolling Hills Estates
Roseville
San Diego
Walnut Creek
Waterbury
Tallahassee
Tampa
Stockbridge
Normal
Shiloh
Evansville
Iowa City
Owensboro
Bangor
Bethesda
Gaithersburg
Brockton
Minneapolis
Plymouth
St Louis
Bellevue
Ocean City
Teaneck
Verona
Rochester
Rockville Centre
Asheville
High Point
Canton
Cincinnati
Tulsa
Medford
Portland
Bethlehem
Blue Bell
Pittsburgh
Providence
Dallas
Kerrville
Plano
San Antonio
South Burlington
Henrico
Bellingham
Seattle
Vancouver
Greenfield
Madison
Milwaukee
Hamilton
London
Niagara
Ottawa
Toronto
Windsor
Montreal
Québec
Saint Romuald
Trois-Rivières
Reims
Gironde
Bas Rhin
Meurthe-et-Moselle
Heidelberg
Essen
Goch
Dresden
Berlin
Hamburg
Ancona
Genova
Milan
Parma
Pavia
Roma
Siena
Almere Stad
Amsterdam
Beek
Durban
eMkhomazi
Ottawa
Cape Town
Sabadell
Santander
Girona
Donostia / San Sebastian
Pamplona
Bilbao
Barcelona
Seville
Quintiles, Inc.
INDUSTRY
Circassia Limited
INDUSTRY